Thomas Hope, MD
University of California, San Francisco · Alliance for Clinical Trials in Oncology
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Thomas Hope, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:43 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07218224 · Expanded Access:18F-Fluorocholine for the Detection of Parathyroid AdenomasThomas Hope · available · Parathyroid Adenomas · principal investigator
- Ph3NCT07200830 · Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL TrialAlliance for Clinical Trials in Oncology · recruiting · Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 · study chair
- Ph2NCT06961084 · Comparison of I-124 PET/CT for the Diagnosis of Thyroid CancerThomas Hope · recruiting · Thyroid Cancer · principal investigator
- N/ANCT05435495 · Mechanisms of Resistance to PSMA Radioligand TherapyUniversity of California, San Francisco · recruiting · Prostate Cancer · principal investigator
- Ph3NCT04895631 · 18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid AdenomasThomas Hope · completed · Hyperparathyroidism, Primary · principal investigator
- Ph1NCT04621435 · Imaging of Solid Tumors Using FAP-2286Thomas Hope · recruiting · Solid Tumors, Adult, Metastatic Cancer · principal investigator
- N/ANCT04377152 · Expanded Access 68Gallium-PSMA-11 PET for Prostate CancerUniversity of California, San Francisco · approved for marketing · Prostate Cancer, Prostate, Prostate Adenocarcinoma · principal investigator
- Ph3NCT03803475 · Gallium-68 PSMA-11 PET Imaging in Prostate Cancer PatientsThomas Hope · completed · Prostate Cancer · principal investigator
- Ph2/Ph3NCT03764007 · 18F-Fluorocholine for the Detection of Parathyroid AdenomasThomas Hope · completed · Hyperparathyroidism, Primary · principal investigator
- Ph3NCT03353740 · Gallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical RecurrenceThomas Hope · completed · Prostate Cancer · principal investigator
- Early Ph1NCT03197012 · Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine TumorThomas Hope · completed · Neuroendocrine Tumor · principal investigator
- Ph2/Ph3NCT02919111 · Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy PatientsUniversity of California, San Francisco · completed · Prostate Cancer · principal investigator
- Ph2/Ph3NCT02918357 · Gallium-68 PSMA-11 PET in Patients With Biochemical RecurrenceUniversity of California, San Francisco · completed · Prostate Cancer · principal investigator
- N/ANCT02233595 · Evaluation of Rectal Cancer Treatment Response Using PET/MRIUniversity of California, San Francisco · terminated · Rectal Adenocarcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:43 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- MELT: Modulation of PSMA Expression for Lutetium TherapyR01CA235741 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Thomas A Hope · fiscal years 2019 to 2025Named on NCT05435495
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.